BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35945128)

  • 1. Validation Study of New IASLC Histology Grading System in Stage I Non-Mucinous Adenocarcinoma Comparing With Minimally Invasive Adenocarcinoma.
    Woo W; Cha YJ; Kim BJ; Moon DH; Lee S
    Clin Lung Cancer; 2022 Nov; 23(7):e435-e442. PubMed ID: 35945128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of resected invasive mucinous adenocarcinoma compared with the IASLC histologic grading system for invasive nonmucinous adenocarcinoma: Surgical database study in the TKIs era in Korea.
    Woo W; Yang YH; Cha YJ; Moon DH; Shim HS; Cho A; Kim BJ; Kim HE; Park BJ; Lee JG; Kim DJ; Paik HC; Lee S; Lee CY
    Thorac Cancer; 2022 Dec; 13(23):3310-3321. PubMed ID: 36345148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The new IASLC grading system for invasive non-mucinous lung adenocarcinoma is a more useful indicator of patient survival compared with previous grading systems.
    Yanagawa N; Sugai M; Shikanai S; Sugimoto R; Osakabe M; Uesugi N; Saito H; Maemondo M; Sugai T
    J Surg Oncol; 2023 Jan; 127(1):174-182. PubMed ID: 36098331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposal of a revised International Association for the Study of Lung Cancer grading system in pulmonary non-mucinous adenocarcinoma: The importance of the lepidic proportion.
    Park BJ; Woo W; Cha YJ; Shim HS; Yang YH; Moon DH; Kim BJ; Kim HE; Kim DJ; Paik HC; Lee JG; Lee S; Lee CY
    Lung Cancer; 2023 Jan; 175():1-8. PubMed ID: 36436241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation Study of the International Association for the Study of Lung Cancer Histologic Grading System of Invasive Lung Adenocarcinoma.
    Rokutan-Kurata M; Yoshizawa A; Ueno K; Nakajima N; Terada K; Hamaji M; Sonobe M; Menju T; Date H; Morita S; Haga H
    J Thorac Oncol; 2021 Oct; 16(10):1753-1758. PubMed ID: 33905897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-grade tumor classified by new system is a prognostic predictor in resected lung adenocarcinoma.
    Yoshida C; Yokomise H; Ibuki E; Go T; Haba R; Kadota K
    Gen Thorac Cardiovasc Surg; 2022 May; 70(5):455-462. PubMed ID: 35050467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the novel International Association for the Study of Lung Cancer grading system and prognostic value of filigree micropapillary and discohesive growth pattern in invasive pulmonary adenocarcinoma.
    Zhang Y; Zhang Y; Hu Y; Zhang S; Zhu M; Hu B; Guo X; Lu J; Zhang Y
    Lung Cancer; 2023 Jan; 175():79-87. PubMed ID: 36481678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Simplified Version of the IASLC Grading System for Invasive Pulmonary Adenocarcinomas With Improved Prognosis Discrimination.
    Bossé Y; Gagné A; Althakfi WA; Orain M; Couture C; Trahan S; Pagé S; Joubert D; Fiset PO; Desmeules P; Joubert P
    Am J Surg Pathol; 2023 Jun; 47(6):686-693. PubMed ID: 37032554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.
    Murakami S; Ito H; Tsubokawa N; Mimae T; Sasada S; Yoshiya T; Miyata Y; Yokose T; Okada M; Nakayama H
    Lung Cancer; 2015 Nov; 90(2):199-204. PubMed ID: 26341957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters.
    Takahashi M; Shigematsu Y; Ohta M; Tokumasu H; Matsukura T; Hirai T
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):54-9. PubMed ID: 24131786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Who benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-dimensional model for candidate selection.
    Jiang MQ; Qian LQ; Shen YJ; Fu YY; Feng W; Ding ZP; Han YC; Fu XL
    Neoplasia; 2024 Apr; 50():100979. PubMed ID: 38387107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of the IASLC grading system of lung adenocarcinoma: a systematic review and meta-analysis.
    Hegedűs F; Zombori-Tóth N; Kiss S; Lantos T; Zombori T
    Histopathology; 2024 Jul; 85(1):51-61. PubMed ID: 38485464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction for prognosis of resected pT1a-1bN0M0 adenocarcinoma based on tumor size and histological status: relationship of TNM and IASLC/ATS/ERS classifications.
    Ito M; Miyata Y; Kushitani K; Yoshiya T; Mimae T; Ibuki Y; Misumi K; Takeshima Y; Okada M
    Lung Cancer; 2014 Aug; 85(2):270-5. PubMed ID: 24976332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating IASLC grading and radiomics for predicting postoperative outcomes in stage IA invasive lung adenocarcinoma.
    Chen Y; Wu J; You J; Gao M; Lu S; Sun C; Shu Y; Wang X
    Med Phys; 2024 May; ():. PubMed ID: 38781536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implication of the 2020 International Association for the Study of Lung Cancer histologic grading in surgically resected pathologic stage 1 lung adenocarcinomas: Prognostic value and association with computed tomography characteristics.
    Cho IS; Shim HS; Lee HJ; Suh YJ
    Lung Cancer; 2023 Oct; 184():107345. PubMed ID: 37611496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The IASLC Proposed Grading System Accurately Predicts Prognosis and Mediastinal Nodal Metastasis in Patients With Clinical Stage I Lung Adenocarcinoma.
    Xu L; Su H; Hou L; Wang F; Xie H; She Y; Gao J; Zhao S; Dai C; Xie D; Zhu Y; Wu C; Zhao D; Chen C;
    Am J Surg Pathol; 2022 Dec; 46(12):1633-1641. PubMed ID: 36224092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiologic Predictors for Clinical Stage IA Lung Adenocarcinoma with Ground Glass Components: A Multi-Center Study of Long-Term Outcomes.
    Li Z; Ye B; Bao M; Xu B; Chen Q; Liu S; Han Y; Peng M; Lin Z; Li J; Zhu W; Lin Q; Xiong L
    PLoS One; 2015; 10(9):e0136616. PubMed ID: 26339917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frozen sections accurately predict the IASLC proposed grading system and prognosis in patients with invasive lung adenocarcinomas.
    Fan J; Yao J; Si H; Xie H; Ge T; Ye W; Chen J; Yin Z; Zhuang F; Xu L; Su H; Zhao S; Xie X; Zhao D; Wu C; Zhu Y; Ren Y; Xu N; Chen C;
    Lung Cancer; 2023 Apr; 178():123-130. PubMed ID: 36822017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and predictive value of the newly proposed grading system of invasive pulmonary adenocarcinoma in Chinese patients: a retrospective multicohort study.
    Hou L; Wang T; Chen D; She Y; Deng J; Yang M; Zhang Y; Zhao M; Zhong Y; Ma M; Zhao G; Chen Y; Xie D; Zhu Y; Chen Q; Wu C; Chen C;
    Mod Pathol; 2022 Jun; 35(6):749-756. PubMed ID: 35013526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of pattern-based grading system by the new IASLC/ATS/ERS classification in Asian patients with stage I lung adenocarcinoma.
    Zhao ZR; Xi SY; Li W; Situ DR; Chen KM; Yang H; Su XD; Lin YB; Long H
    Lung Cancer; 2015 Dec; 90(3):604-9. PubMed ID: 26547801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.